MSK Doctors has released a new report detailing the positive impact that Arthrosamid has had on recent knee osteoarthritis patients, exploring the innovative hydrogel injection treatment in depth.
-- The new release draws largely from Professor Paul Lee’s personal experience in prescribing and providing Arthrosamid injections for those in need. As one of MSK Doctors’ foremost Orthopaedic Consultants, Professor Lee is well-positioned to highlight the hydrogel’s suitability for knee osteoarthritis patients - as he does in this recent resource.
For more information, see https://mskdoctors.com/doctors/paul-lee/articles/why-arthrosamid-is-a-leading-choice-for-knee-osteoarthritis-treatment-insights-from-professor-paul-lees-clinical-experience
Lee writes in detail about the unique, reconstructive approach involved with Arthrosamid procedures. In comparison to alternative knee osteoarthritis treatments, the report brings attention to the way that Arthrosamid augments the soft tissue lining knee joints - a central factor in its effectiveness, argues Lee.
And the results he’s seen with this method have been significantly encouraging for those who've dealt with the debilitating effects of knee osteoarthritis for some time.
“Over the past three years, administering nearly 250 Arthrosamid injections, I have witnessed dramatic improvements in many patients,” writes Professor Lee. “These changes are especially pronounced in those who had not responded to other forms of injections. The ability of Arthrosamid to provide relief in these advanced cases is a significant development in the field.”
As such, Lee directly frames the development of Arthrosamid as news that will be welcome to those who are less than keen on the idea of knee surgery. For many, surgical treatment is often a last resort that they’d sooner avoid, or delay - if given a choice. According to Professor Lee, then, such a choice is now available.
It’s for this reason that Lee urges knee osteoarthritis sufferers to explore the suitability of Arthrosamid for their condition. In the UK, patients can use MSK Doctors’ private clinician referral platform to find a consultant with the requisite expertise to discuss Arthrosamid’s prospects - as well as its likelihood of success in their unique case.
Should its doctors recommend Arthrosamid as a viable treatment, MSK Doctors is then equipped to provide injections at local clinics - targeting lasting improvements.
Professor Lee concludes: “For many patients, Arthrosamid offers a much-needed respite - extending the time before more invasive procedures become necessary.”
Interested parties can find further details at: https://mskdoctors.com/
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89157431
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
